These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 4715827)

  • 1. [Psychological diagnosis of thought disorders in schizophrenia].
    Ostaszewska J; Stanikowska I
    Psychiatr Pol; 1973; 7(1):17-22. PubMed ID: 4715827
    [No Abstract]   [Full Text] [Related]  

  • 2. An analysis of the cognitive deficit of schizophrenia based on the Piaget developmental theory.
    Torres A; Olivares JM; Rodriguez A; Vaamonde A; Berrios GE
    Compr Psychiatry; 2007; 48(4):376-9. PubMed ID: 17560960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intellectual capacity measurement in schizophrenia.
    Chamorro L; de Felipe MV; Soler MM; Olivares D; Huertas D
    Actas Esp Psiquiatr; 2008; 36(1):33-8. PubMed ID: 18286398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CANTAB explicit memory is less impaired in addicted schizophrenia patients.
    Potvin S; Briand C; Prouteau A; Bouchard RH; Lipp O; Lalonde P; Nicole L; Lesage A; Stip E
    Brain Cogn; 2005 Oct; 59(1):38-42. PubMed ID: 15913868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological subtyping of schizophrenia.
    Ilonen T; Taiminen T; Karlsson H; Lauerma H; Leinonen KM; Wallenius E; Salokangas RK
    Psychiatry Res; 2004 Dec; 129(2):191-9. PubMed ID: 15590046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does operational diagnosis of schizophrenia significantly impact intellectual deficits in psychotic disorders?
    Kitamura H; Shioiri T; Itoh M; Sato Y; Shichiri K; Someya T
    J Intellect Disabil Res; 2007 Oct; 51(Pt 10):812-20. PubMed ID: 17803499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disorders in cognition and language vs. communication deviances in families of schizophrenics].
    Nieznański M
    Psychiatr Pol; 1999; 33(3):399-406. PubMed ID: 10786239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emotion recognition, 'theory of mind,' and social behavior in schizophrenia.
    Brüne M
    Psychiatry Res; 2005 Feb; 133(2-3):135-47. PubMed ID: 15740990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological frontal impairments and negative symptoms in schizophrenia.
    Martino DJ; Bucay D; Butman JT; Allegri RF
    Psychiatry Res; 2007 Aug; 152(2-3):121-8. PubMed ID: 17507100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.
    Harvey PD; Serper MR; White L; Parrella MJ; McGurk SR; Moriarty PJ; Bowie C; Vadhan N; Friedman J; Davis KL
    Compr Psychiatry; 2001; 42(4):306-13. PubMed ID: 11458305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive correlates of response to treatment in formal thought disorder in patients with first-episode schizophrenia.
    Goldstein RZ; Giovannetti T; Schullery M; Zuffante PA; Lieberman JA; Robinson DG; Barr WB; Bilder RM
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):88-98. PubMed ID: 12050471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Correlation between cognitive functioning and the symptomatology of schizophrenia.
    Stip E
    Can J Psychiatry; 1998 Oct; 43(8):854-5. PubMed ID: 9806094
    [No Abstract]   [Full Text] [Related]  

  • 13. Cognitive discernible factors between schizophrenia and schizoaffective disorder.
    Stip E; Sepehry AA; Prouteau A; Briand C; Nicole L; Lalonde P; Lesage A
    Brain Cogn; 2005 Dec; 59(3):292-5. PubMed ID: 16125294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects.
    White T; Ho BC; Ward J; O'Leary D; Andreasen NC
    Biol Psychiatry; 2006 Sep; 60(5):463-71. PubMed ID: 16566898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indicators of genetic liability to schizophrenia: a sibling study of neuropsychological performance.
    Thompson JL; Watson JR; Steinhauer SR; Goldstein G; Pogue-Geile MF
    Schizophr Bull; 2005 Jan; 31(1):85-96. PubMed ID: 15888428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurocognitive deficits in schizophrenia].
    Rund BR
    Tidsskr Nor Laegeforen; 2002 Aug; 122(20):2019-22. PubMed ID: 12555450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia.
    Heslegrave RJ; Awad AG; Voruganti LN
    J Psychiatry Neurosci; 1997 Jul; 22(4):235-43. PubMed ID: 9262045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatological and cognitive predictors of insight in chronic schizophrenia.
    Nakano H; Terao T; Iwata N; Hasako R; Nakamura J
    Psychiatry Res; 2004 Jun; 127(1-2):65-72. PubMed ID: 15261706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thought disorder in schizophrenia is associated with both executive dysfunction and circumscribed impairments in semantic function.
    Stirling J; Hellewell J; Blakey A; Deakin W
    Psychol Med; 2006 Apr; 36(4):475-84. PubMed ID: 16403241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.